A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations

Nat Commun. 2024 May 3;15(1):3745. doi: 10.1038/s41467-024-47945-7.

Abstract

Early childhood tumours arise from transformed embryonic cells, which often carry large copy number alterations (CNA). However, it remains unclear how CNAs contribute to embryonic tumourigenesis due to a lack of suitable models. Here we employ female human embryonic stem cell (hESC) differentiation and single-cell transcriptome and epigenome analysis to assess the effects of chromosome 17q/1q gains, which are prevalent in the embryonal tumour neuroblastoma (NB). We show that CNAs impair the specification of trunk neural crest (NC) cells and their sympathoadrenal derivatives, the putative cells-of-origin of NB. This effect is exacerbated upon overexpression of MYCN, whose amplification co-occurs with CNAs in NB. Moreover, CNAs potentiate the pro-tumourigenic effects of MYCN and mutant NC cells resemble NB cells in tumours. These changes correlate with a stepwise aberration of developmental transcription factor networks. Together, our results sketch a mechanistic framework for the CNA-driven initiation of embryonal tumours.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation*
  • Cell Line, Tumor
  • Chromosome Aberrations
  • DNA Copy Number Variations*
  • Female
  • Gene Expression Regulation, Neoplastic
  • Human Embryonic Stem Cells / metabolism
  • Humans
  • N-Myc Proto-Oncogene Protein* / genetics
  • N-Myc Proto-Oncogene Protein* / metabolism
  • Neural Crest* / metabolism
  • Neural Crest* / pathology
  • Neuroblastoma* / genetics
  • Neuroblastoma* / pathology
  • Transcriptome

Substances

  • N-Myc Proto-Oncogene Protein
  • MYCN protein, human

Grants and funding